Newsroom

BRUSSELS--(BUSINESS WIRE)--Arthur D. Little and Invest Europe have released 'The Insight: State of the European Private Equity Industry 2026’, an annual market sentiment report....

DALLAS e OSS, Paesi Bassi--(BUSINESS WIRE)--Trained Therapeutix Discovery ("TTxD"), azienda pioniera nell'immunoterapia fondata dal Jean Boulle Group e dall'Heritage Group, che sviluppa nanofarmaci per regolare l'immunità innata, annuncia la nomina di Andrew Glass all'incarico di amministratore delegato con effetto immediato. Glass vanta oltre 20 anni di esperienza dirigenziale nel settore delle scienze della vita come AD di Vivasure Medical e in precedenza oltre 15 anni in ruoli dirigenziali s...

BERLÍN--(BUSINESS WIRE)--Xsolla, una empresa global de comercio de videojuegos que ayuda a los desarrolladores a lanzar, hacer crecer y monetizar sus juegos, anuncia hoy un programa integral de activaciones en Berlín durante noviembre de 2026. Como socio principal de Games Ground Berlin, Xsolla apoya el programa Publisher Connect del festival y organiza Xsolla Connect Berlin: Publisher & Content Creator Edition, para unir a desarrolladores, editores y creadores con el objetivo de que explor...

BERLIN--(BUSINESS WIRE)--Xsolla, ein weltweit tätiges Unternehmen im Bereich Videospiel-E-Commerce, das Entwickler bei der Markteinführung, dem Ausbau und der Monetarisierung ihrer Spiele unterstützt, kündigt heute ein umfassendes Programm mit Veranstaltungen in ganz Berlin für den November 2026 an. Als Hauptpartner von Games Ground Berlin unterstützt Xsolla das „Publisher Connect“-Programm des Festivals und veranstaltet die „Xsolla Connect Berlin: Publisher & Content Creator Edition“, bei...

DALLAS & OSS, Nederland--(BUSINESS WIRE)--Trained Therapeutix Discovery ('TTxD'), een baanbrekend immunotherapiebedrijf opgericht door de Jean Boulle Group en de Heritage Group, dat zich richt op de ontwikkeling van nanomedicijnen voor het reguleren van de aangeboren immuniteit, kondigt de benoeming aan van Andrew Glass tot Chief Executive Officer, met onmiddellijke ingang. Dhr. Glass beschikt over meer dan 20 jaar leidinggevende ervaring in de life sciences-sector; zo was hij eerder Chief Exec...

HOUSTON--(BUSINESS WIRE)--The Lanier Law Firm has earned the esteemed Law Firm of the Year award from Best Law Firms as the nation’s top legal practice for plaintiffs mass tort litigation and class actions. Along with this achievement, the firm retained its national honor in appellate practice. The firm’s offices in Houston, New York City and Los Angeles also earned placements in the guide for excellence across 10 practice areas. The Houston office earned Tier 1 rankings, the highest possible,...

DALLAS--(BUSINESS WIRE)--Johnston Tobey Baruch, a Texas trial and appellate law firm, has again been recognized among the nation’s top legal practices in the 2027 edition of Best Law Firms. The respected legal guide awarded the boutique firm seven Tier 1 rankings for the Dallas/Fort Worth region, highlighting its deep expertise across commercial disputes, professional liability and appellate advocacy. The firm was also highly ranked for its work in complex, high-stakes "bet-the-company" litigat...

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) oggi ha annunciato la presentazione di nuovi dati in più di 30 abstract che illustrano il progresso nel suo portafoglio ematologico al Congresso annuale 2026 della American Society of Hematology (ASH), che si svolgerà dal 12 al 15 dicembre 2026 a New Orleans. Il testo originale del presente annuncio, redatto nella lingua di partenza, è la versione ufficiale che fa fede. Le traduzioni sono offerte unicamente per comodità del lettore e devon...

DALLAS E OSS, Países Baixos--(BUSINESS WIRE)--A Trained Therapeutix Discovery (“TTxD”), empresa pioneira em imunoterapia fundada pelos grupos Jean Boulle e Heritage, que desenvolve nanomedicamentos para modular a imunidade inata, anunciou a nomeação de Andrew Glass como CEO, com efeito imediato. O executivo traz mais de 20 anos de experiência em liderança no setor de ciências da vida como diretor executivo da Vivasure Medical e, anteriormente, trabalhou por mais de 15 anos em cargos de alta ges...

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq: INCY) gab heute bekannt, dass neue Daten, die die Fortschritte im gesamten hämatologischen Portfolio des Unternehmens beleuchten, in mehr als 30 Abstracts auf der Jahrestagung 2026 der American Society of Hematology (ASH) vorgestellt werden, die vom 12. bis 15. Dezember 2026 in New Orleans stattfindet. „Unsere ASH-Präsentationen belegen bedeutende Fortschritte in unserem gesamten Hämatologie-Portfolio, um neuartige Behandlungsansätze für Mensch...